Single-Cell RNA Sequencing Reveals HIF1A as a Severity-Sensitive Immunological Scar in Circulating Monocytes of Convalescent Comorbidity-Free COVID-19 Patients

Lilly May,Chang-Feng Chu,Christina E. Zielinski
DOI: https://doi.org/10.3390/cells13040300
IF: 6
2024-02-07
Cells
Abstract:COVID-19, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is characterized by a wide range of clinical symptoms and a poorly predictable disease course. Although in-depth transcriptomic investigations of peripheral blood samples from COVID-19 patients have been performed, the detailed molecular mechanisms underlying an asymptomatic, mild or severe disease course, particularly in patients without relevant comorbidities, remain poorly understood. While previous studies have mainly focused on the cellular and molecular dissection of ongoing COVID-19, we set out to characterize transcriptomic immune cell dysregulation at the single-cell level at different time points in patients without comorbidities after disease resolution to identify signatures of different disease severities in convalescence. With single-cell RNA sequencing, we reveal a role for hypoxia-inducible factor 1-alpha (HIF1A) as a severity-sensitive long-term immunological scar in circulating monocytes of convalescent COVID-19 patients. Additionally, we show that circulating complexes formed by monocytes with either T cells or NK cells represent a characteristic cellular marker in convalescent COVID-19 patients irrespective of their preceding symptom severity. Together, these results provide cellular and molecular correlates of recovery from COVID-19 and could help in immune monitoring and in the design of new treatment strategies.
cell biology
What problem does this paper attempt to address?
The problems that this paper attempts to solve are: in recovered COVID - 19 patients without complications, to reveal the long - term immunological characteristics under different disease severities through single - cell RNA sequencing, especially to explore whether Hypoxia - inducible factor 1 - alpha (HIF1A) can be used as a long - term immunological trace sensitive to disease severity in circulating monocytes. Specifically, the paper aims to: 1. **Identify long - term immunological traces**: By analyzing the single - cell transcriptomes of patients in the convalescent period, look for long - term immunological characteristics related to different disease severities. 2. **Explore the role of HIF1A**: Study the expression of HIF1A in circulating monocytes and its relationship with disease severity. 3. **Evaluate the changes in immune cell composition**: Examine whether the immune cell composition in the blood of recovered patients at different time points (2 weeks, 4 weeks, 6 weeks) is stable, and whether these changes are related to disease severity. 4. **Exclude the influence of other immune markers**: Verify the expression of known COVID - 19 - related immune markers (such as cytokines, chemokines and MHC molecules) in patients in the convalescent period to determine whether they still exist or disappear. Through these research objectives, the authors hope to provide a new perspective for understanding the long - term immunological effects of COVID - 19 and provide a basis for future immune monitoring and treatment strategy design.